Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended June 30, 2008, for Wound Management Technologies, Inc. (formerly MB Software Corporation). The company operates in the advanced wound care market through its subsidiary, Wound Care Innovations, LLC, marketing the "CellerateRx" product line. The company is classified as a smaller reporting company and a shell company is not applicable.
Key Financial Metrics
| Metric | Six Months Ended June 30, 2008 | Six Months Ended June 30, 2007 |
|---|---|---|
| Total Revenue | $138,400 | $384,046 |
| Cost of Revenue | $219,525 | $137,440 |
| Gross Profit (Loss) | ($81,125) | $246,606 |
| Net Loss | ($586,738) | ($189,403) |
| Cash and Cash Equivalents (End of Period) | $92,544 | $13,503 |
| Total Current Assets | $1,167,483 | $382,395 |
| Total Current Liabilities | $1,743,504 | $2,219,510 |
| Stockholders' Deficiency | ($554,854) | ($1,813,780) |
Debt and Liquidity: The company holds $710,000 in notes payable to unrelated parties and $327,780 in notes payable to related parties. Accrued interest to related parties totals approximately $244,998. The company reported a net cash outflow from operating activities of $525,407 for the six-month period, offset by $1,325,370 in financing activities.
Material Changes vs. Prior Period
- Revenue Decline: Revenue decreased approximately 64% to $138,400 from $384,046 in the prior year period.
- Gross Margin Reversal: The company shifted from a gross profit of $246,606 in 2007 to a gross loss of $81,125 in 2008, driven by cost of revenue exceeding total revenue.
- Increased Losses: Net loss widened significantly to $586,738 compared to $189,403 in the prior year.
- Capital Structure Changes: The company converted $1,495,664 of related party debt into Series A Preferred Stock (later converted to 7.6 million common shares) and raised $1,000,000 in new capital ($300,000 equity, $700,000 convertible note) during the period.
Outlook, Risks, and Contingencies
Going Concern: The filing explicitly states that conditions raise substantial doubt about the company's ability to continue as a going concern. The company has a significant accumulated deficit of $13.6 million and expects to continue incurring losses for the next twelve months. Continued operations depend on obtaining additional financing or equity capital.
Management Commentary: Management plans to raise capital through private placements, issue stock for services, and obtain loans from shareholders. The company intends to expand staff and marketing efforts if capital is secured.
Risks and Contingencies:
- Tax Delinquency: The company is delinquent on federal payroll taxes, with unpaid liabilities of approximately $203,000 and estimated penalties/interest of $145,000 as of June 30, 2008.
- Product Liability: The company faces inherent risks regarding product liability claims and adverse publicity, with no contractual indemnification anticipated.
- Financing Risk: Failure to secure additional funds may force the company to curtail or cease activities.
Investor Verification Checklist
- Verify the status of the $203,000 unpaid federal payroll tax liability and the $145,000 in associated penalties.
- Confirm the company's ability to secure the additional financing required to maintain operations for the next 12 months.
- Review the details of the $710,000 note payable to an investment firm, which is noted as currently in default.
- Assess the sustainability of the revenue model given the 64% year-over-year decline and negative gross margin.
- Validate the conversion of debt to equity and the resulting dilution of existing shareholders (7.6 million new shares issued).